title: Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.
abstract: Type 2 diabetes mellitus (T2DM) is a major chronic disease that is prevalent worldwide, and it is characterized by an increase in blood glucose, disturbances in the metabolism, and alteration in insulin secretion. Nowadays, food-based therapy has become an important treatment mode for type 2 diabetes, and phytobioactive compounds have gained an increasing amount of attention to this end because they have an effect on multiple biological functions, including the sustained secretion of insulin and regeneration of pancreatic islets cells. However, the poor solubility and lower permeability of these phyto products results in a loss of bioactivity during processing and oral delivery, leading to a significant reduction in the bioavailability of phytobioactive compounds to treat T2DM. Recently, nanotechnological systems have been developed for use as various types of carrier systems to improve the delivery of bioactive compounds and thus obtain a greater bioavailability. Furthermore, carrier systems in most nanodelivery systems are highly biocompatible, with nonimmunologic behavior, a high degree of biodegradability, and greater mucoadhesive strength. Therefore, this review focuses on the various types of nanodelivery systems that can be used for phytobioactive compounds in treating T2DM with greater antidiabetic effects. There is also additional focus on improving the effects of various phytobioactive compounds through nanotechnological delivery to ensure a highly efficient treatment of type 2 diabetes.
authors.affiliation: Nanotechnology Research Center and Department of Applied Life Science; Department of Biotechnology, College of Biomedical and Health Science, Konkuk University, Chungju, Republic of Korea.
authors.forename: Palanivel
authors.initials: P
authors.lastname: Ganesan
authors.affiliation: Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Malaysia.
authors.forename: Palanisamy
authors.initials: P
authors.lastname: Arulselvan
authors.affiliation: Nanotechnology Research Center and Department of Applied Life Science; Department of Biotechnology, College of Biomedical and Health Science, Konkuk University, Chungju, Republic of Korea.
authors.forename: Dong-Kug
authors.initials: DK
authors.lastname: Choi
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D016503:Drug Delivery Systems; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D053758:Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D010936:Plant Extracts / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D010936:Plant Extracts
keywords: nanodelivery system; oral delivery; phytobioactive compounds; type 2 diabetes